Skip to main content

Table 1 Demographic and clinicopathological information for subjects included in this study

From: The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk

Factors

Categories

Pathogenecity, number (%)

P

Pathogenic

Likely pathogenic

Non-pathogenic

Gender

     
 

Female

21 (35.6)

10 (19.2)

15 (15.8)

0.013

 

Male

38 (64.4)

42 (80.8)

80 (84.2)

Age

     
 

 < 40

2 (3.4)

3 (5.8)

3 (3.2)

0.963

 

40–49

6 (10.2)

6 (11.5)

9 (9.5)

 

50–59

19 (32.2)

17 (32.7)

25 (26.3)

 

60–69

17 (28.8)

12 (23.1)

33 (34.7)

 

70–79

12 (20.3)

10 (19.2)

20 (21.0)

 

 >  = 80

3 (5.1)

4 (7.7)

5 (5.3)

Stage

     
 

I

7 (11.9)

5 (9.6)

10 (10.5)

0.685

 

II

0 (0.0)

2 (3.9)

2 (2.1)

 

III

4 (6.8)

1 (1.9)

2 (2.1)

 

IV

0 (0.0)

1 (1.9)

2 (2.1)

 

Not specified

48 (81.3)

43 (82.7)

79 (83.2)

Race

     
 

Asian

1 (1.7)

2 (3.8)

4 (4.2)

0.688

 

African American

8 (13.6)

8 (15.4)

7 (7.4)

 

White

38 (64.4)

31 (59.6)

59 (62.1)

 

Not specified

12 (20.3)

11 (21.2)

25 (26.3)

Cancer

     
 

BLCA

17 (28.8)

13 (25.0)

18 (18.9)

0.736

 

KICH

2 ( 3.4)

2 ( 3.8)

3 (3.2)

 

KIRC

14 (23.7)

8 (15.4)

22 (23.2)

 

KIRP

12 (20.4)

14 (27.0)

19 (20.0)

 

PRAD

14 (23.7)

15 (28.8)

33 (34.7)

Ethnicity

     
 

African

11 (18.6)

10 (19.2)

13 (13.7)

0.774

 

American

1 (1.7)

2 (3.8)

2 (2.1)

 

Asian

1 (1.7)

2 (3.8)

4 (4.2)

 

European

46 (78.0)

37 (71.3)

76 (80.0)

 

Mix

0 (0.0)

1 (1.9)

0 (0.0)

 

Total

59

52

95